UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 18, 2007
GENOPTIX, INC. | ||||
(Exact name of registrant as specified in its charter) | ||||
|
|
|
|
|
Delaware |
| 001-33753 |
| 33-0840570 |
(State or other jurisdiction of incorporation) |
| (Commission File Number) |
| (I.R.S. Employer Identification No.) |
|
|
|
|
|
|
| 2110 Rutherford Road |
|
|
|
| Carlsbad, CA 92008 |
|
|
(Address of principal executive offices and zip code) | ||||
|
|
|
|
|
Registrant’s telephone number, including area code: (760) 268-6200 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(e) On December 18, 2007, the Compensation Committee of the Board of Directors (the “Committee”) of Genoptix, Inc. (“Genoptix”), in connection with its 2007 annual bonus compensation review for Genoptix executive officers, amended its 2007 Annual Executive Bonus Plan and awarded bonuses to the executive officers listed below. The 2007 target bonus percentages under the 2007 Annual Executive Bonus Plan, as amended, is set forth in the chart below.
| 2007 Target Bonus |
Dr. Tina Nova Bennett | 40% |
Samuel D. Riccitelli | 30% |
Douglas A. Schuling | 30% |
Under the 2007 Annual Executive Bonus Plan, as amended, the Committee has the discretion to award a bonus for each executive officer equal to an amount from 0 to 200% of the applicable target bonus percentages. In connection with its 2007 annual bonus compensation review, the Committee awarded 2007 performance bonuses of $306,260 to Dr. Nova Bennett, $212,792 to Mr. Riccitelli and $161,722 to Mr. Schuling.
The text of the 2007 Annual Executive Bonus Plan, as amended, is attached as Exhibit 99.1 to this Current Report and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 | 2007 Annual Executive Bonus Plan, as amended.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
| GENOPTIX, INC. | |
|
|
|
|
|
Dated: December 20, 2007 |
|
| By: | /s/ Christian V. Kuhlen |
|
|
|
| Christian V. Kuhlen, M.D., Esq. |
|
|
|
| Vice President, General Counsel |
|
|
|
|
|
EXHIBIT INDEX
Exhibit |
|
|
Number |
| Description |
99.1 |
| 2007 Annual Executive Bonus Plan, as amended. |